MEDICINE

Patient Care
Treatment Centers
Ambulatory Treatment Center
Michael Overman, MD
Center Medical Director
Brenda Brown, RN, MSN, OCN, NE-BC
Clinical Administrative Director
11,604
377,693
118,097
384
Follow-ups
Procedures
Patient Visits
Average patients per weekday
10
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
The Ambulatory Treatment Center (ATC), with 156 beds and 5 clinical
sites, delivers infusion therapy for all of MD Anderson’s specialty centers.
The ATC provides treatments for the adult patient population, 18 years of
age and beyond.
ATC services include:
• Infusions of standard and investigational chemotherapy regimens
• Transfusion of blood products and immunoglobulin infusions
• Administration of fluids and electrolyte replacement
• Injections of all types
• Infusions of antibiotics, anti-fungals and anti-virals
• Infusion pump connections and disconnections
Clinical Center for Targeted Therapy
David Hong, MD
Center Medical Director
Cheryl Fullmer, RN, MBA
Clinical Administrative Director
The Clinical Center for Targeted Therapy (CCTT) is the outpatient
arm of the Department of Investigational Cancer Therapeutics (ICT)
that screens for eligibility and monitors patients with a wide variety of
advanced cancers on early-phase clinical trials for the institution. The
center also offers participation in clinical trials for underserved populations
that are traditionally excluded from early-phase studies — children, the
elderly, patients with active brain metastases, and those with hepatic or
renal failure. The center welcomes patient referrals from outside of MD
Anderson as well as from physicians throughout the institution.
ICT also operates an inpatient service, mostly for patients on Phase I
protocols who require overnight monitoring for high-risk and first-in-human
trials, and for patients receiving hepatic arterial infusions. This inpatient
care also extends
to any patient who
is on or off trial
needing inpatient
management of
treatment side
effects, disease
complications, or
co-morbidities.
2,610
231
1,594
1,027
106
24,873
Total patients served
New patients
Consults
Patients enrolled in clinical trials
Number of clinical trials
Ambulatory care visits
Clinical & Translational Research Center
Daniel Karp, MD
Center Medical Director
We have seen
a steady increase in
average daily census
with a growth rate of
3.9% from FY14
to FY15.
Cheryl Fullmer, RN, MBA,
Clinical Administrative
Director
123
101
251
Passion Lockett, DrPH
Assistant Director
The Clinical and Translational Research Center (CTRC) is a dedicated
unit for intensive monitoring of patients participating in complex, early-phase
clinical trials. A team of outstanding nurses and other clinical staff implement
CTRC-approved protocols. Patients are monitored and evaluated, and
interventions are made as needed.
The center also facilitates “basket” trials in which patients across multiple
disease sites and types are assigned to a treatment study arm according to
their mutations revealed on molecular testing, instead of according to their
disease site of origin. More of these protocols are being considered for the
coming year.
The CTRC Laboratory is housed within the clinic to provide sample
collection, processing, storage, and shipping services to support
pharmacologic studies. Clinical investigation technicians collect and process
primarily blood specimens for the studies. Passion Lockett, DrPH,
assistant director, oversees data entry into the Lab Tracker system, which
improves sample quality and efficiency
by electronically tracking every step in
the process from collection to testing,
storage, and shipping in order to better
document specimens used to develop
new drugs or new drug combinations.
Approved Protocols
Activated Protocols
Active Protocols